Suppr超能文献

微创视频辅助甲状旁腺切除术(MIVAP),术中不测定 PTH。

Minimally invasive video-assisted parathyroidectomy (MIVAP) without intraoperative PTH determination.

机构信息

Department of Otolaryngology, Hospital Universitario Central de Asturias, IUOPA, University of Oviedo, Centro de Investigación Biomédica en Red de Cancer (CIBERONC), Oviedo, Spain.

Instituto de Investigación Sanitaria del Principado de Asturias and Centro de Investigación Biomédica en Red de Cancer (CIBERONC), ISCIII, Oviedo, Spain.

出版信息

Eur Arch Otorhinolaryngol. 2021 Dec;278(12):4997-5001. doi: 10.1007/s00405-021-06740-6. Epub 2021 Mar 13.

Abstract

BACKGROUND

Minimally invasive video-assisted parathyroidectomy (MIVAP) has become a standard approach to primary hyperparathyroidism (pHPT) since described. Although intraoperative parathyroid hormone assay (IOPTH) has been generalized as a complementary technique to MIVAP, its actual impact on the surgical success of this technique is not without controversy. The aim of this study was to describe our results in the management of pHPT with successful preoperative localization, by MIVAP technique, without IOPTH determination, confirming in a larger series our preliminary results.

METHODS

A retrospective descriptive study was conducted in pHPT patients treated by MIVAP with no IOPTH determination in a tertiary hospital between 2007 and 2019.

RESULTS

A total of 167 patients were included in the study. Biochemical cure was achieved in 96.4%, and 94.1% did not present any surgical complication. The mean duration of surgery was 61 min, and the mean length of hospital stay was 1.8 days CONCLUSIONS: In case of positive preoperative localization studies, MIVAP is a safe and effective technique for the surgical treatment of pHPT due to a parathyroid adenoma, regardless of IOPTH determination, with a success rate > 95% and a low complication rate.

摘要

背景

微创视频辅助甲状旁腺切除术(MIVAP)自描述以来已成为原发性甲状旁腺功能亢进症(pHPT)的标准治疗方法。虽然术中甲状旁腺激素测定(IOPTH)已被广泛用作 MIVAP 的补充技术,但它对该技术手术成功率的实际影响并非没有争议。本研究的目的是描述我们在 pHPT 管理方面的结果,这些患者通过 MIVAP 技术进行了成功的术前定位,而没有进行 IOPTH 测定,通过更大的系列证实了我们的初步结果。

方法

在 2007 年至 2019 年期间,在一家三级医院中,对接受 MIVAP 治疗且未进行 IOPTH 测定的 pHPT 患者进行了回顾性描述性研究。

结果

共有 167 例患者纳入研究。生化治愈率达到 96.4%,且 94.1%的患者未发生任何手术并发症。手术平均持续时间为 61 分钟,平均住院时间为 1.8 天。

结论

在术前定位研究呈阳性的情况下,MIVAP 是一种安全有效的治疗甲状旁腺腺瘤引起的 pHPT 的手术技术,无论是否进行 IOPTH 测定,成功率均>95%,并发症发生率低。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验